| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AZD4547 | CTRPv2 | pan-cancer | AAC | 0.0089 | 0.8 |
| mRNA | sitagliptin | CTRPv2 | pan-cancer | AAC | 0.017 | 0.8 |
| mRNA | Parthenolide | GDSC1000 | pan-cancer | AAC | 0.016 | 0.8 |
| mRNA | PHA-665752 | GDSC1000 | pan-cancer | AAC | -0.016 | 0.8 |
| mRNA | PHA-793887 | CTRPv2 | pan-cancer | AAC | -0.007 | 0.8 |
| mRNA | Carboplatin | CTRPv2 | pan-cancer | AAC | 0.0081 | 0.8 |
| mRNA | Salubrinal | GDSC1000 | pan-cancer | AAC | 0.015 | 0.8 |
| mRNA | selumetinib:navitoclax (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0079 | 0.8 |
| mRNA | procarbazine | CTRPv2 | pan-cancer | AAC | -0.0086 | 0.8 |
| mRNA | leptomycin B | CTRPv2 | pan-cancer | AAC | -0.0072 | 0.8 |